# MELAMISA
> **ANDA202016** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2016-01-26
## Drug
- **FDA Application Number:** ANDA202016
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MELAMISA
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **First approval:** 2016-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202016)
---
*AI Analytics · CC0 1.0*